Washington officials say after the U.S. Supreme Court upheld broad access to the abortion pill mifepristone Thursday, the state will start to release its stockpile of the drug. But it’s unclear whether the state will renew that stockpile if the medication faces additional federal challenges.
In their unanimous decision, the Supreme Court justices decided the plaintiffs in the case didn’t have the legal standing to sue, preserving the drug’s Food and Drug Administration-approved status.